Company intelligence / Profile preview

SceneRay

Suzhou City, Jiangsu Province, Chinasceneray.com ↗

Ownership: Private
Development stage: Commercial

Overview

SceneRay’s drug detoxification deep brain stimulation system has shown promising results in reducing psychological craving and relapse rates among drug addicts. Initial single-center trials demonstrated efficacy and safety, with results published internationally. The product was the first of its kind to receive "Innovative Green Channel" approval from the Chinese regulator. Ongoing national multi-center randomized controlled trials are further validating its effectiveness.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceDeep brain stimulation system (DBS)
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with major academic hospitals and research institutes

Beyond the preview

Go deeper on SceneRay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SceneRay.

Explore the full profile